Mercury Activates Phospholipase A₂ and Induces Formation of Arachidonic Acid Metabolites in Vascular Endothelial Cells

REFERENCES

• Antoniotti S., Fiorio P. A., Pregnolato S., Mottola A., Lovisolo D., Munaron L. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach. J. Cell Physiol. 2003; 197(3)370–378
   PubMed Web of Science ®Google Scholar
• Aschner M. Astrocyte swelling, phospholipase A2, glutathione and glutamate: interactions in methylmercury-induced neurotoxicity. Cell Mol Biol. (Noisy-le-grande) 2000; 46(4)843–854
   PubMed Web of Science ®Google Scholar
• Balsinde J., Winstead M. V., Dennis E. A. Phospholipase A2 regulation of arachidonic acid mobilization. FEBS Lett 2000; 531: 2–6
   Web of Science ®Google Scholar
• Blanusa M., Varnai V. M., Piasek M., Kostial K. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr. Med. Chem. 2005; 12(23)2771–2794
   PubMed Web of Science ®Google Scholar
• Boening D. W. Ecological effects, transport, and fate of mercury: a general review. Chemosphere 2000; 40: 1335–1351
   PubMed Web of Science ®Google Scholar
• Boffetta P., Sallsten G., Garcia-Gomez M., Pompe-Kirn V., Zaridze D., Bulbulyan M., Caballero J. D., Ceccarelli F., Kobal A. B., Merler E. Mortality from cardiovascular disease and exposure to inorganic mercury. Occup. Environ. Med. 2001; 58: 461–466
   PubMed Web of Science ®Google Scholar
• Bogatcheva N. V., Sergeeva M. G., Dudek S. M., Verin A. D. Arachidonic acid cascade in endothelial pathobiology. Microvasc. Res. 2005; 69: 107–127
   PubMed Web of Science ®Google Scholar
• Chakraborti S. Phospholipase A2 isoforms: a perspective. Cell Signal 2003; 15: 637–665
   PubMed Web of Science ®Google Scholar
• Chan H. M., Egeland G. M. Fish consumption, mercury exposure, and heart disease. Nutr. Rev. 2004; 62: 68–72
   PubMed Web of Science ®Google Scholar
• Clarkson T. W. The three modern faces of mercury. Environ. Health Perspect. 2002; 110: 11–23
   PubMed Web of Science ®Google Scholar
• Clarkson T. W., Magos L., Myers G. J. The toxicology of mercury-current exposures and clinical manifestations. N. Engl. J. Med. 2003; 349: 1731–1737
   PubMed Web of Science ®Google Scholar
• Dennis E. A., Rhee S. G., Billah M. M., Hannun Y. A. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 1991; 5: 2068–2077
   PubMed Web of Science ®Google Scholar
• Divecha N., Irvine R. F. Phospholipid signaling. Cell 1995; 80: 269–278
   PubMed Web of Science ®Google Scholar
• Dopp E., Hartman L. M., Florea A. M., Rettenmeier A. W., Hirner A. V. Environmental distribution, analysis, and toxicity of organometal (loid) compounds. Crit. Rev. Toxicol. 2004; 34: 301–333
   PubMed Web of Science ®Google Scholar
• Egermayer P. Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?. J. Intern. Med. 2000; 247: 11–17
   PubMed Web of Science ®Google Scholar
• Hagele T. J., Mazerik J. N., Gregory A., Kaufman B., Magalang U., Kuppusamy M., Marsh C. B., Kuppusamy P., Parinandi N. L. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int. J. Toxicol. 2006; 26(1)57–69
   Web of Science ®Google Scholar
• Hare M. F., McGinnis K. M., Atchison W. D. Methylmercury increases intracellular concentrations of Ca++ and heavy metals in NG108–15 cells. J. Pharmacol. Exp. Ther. 1993; 266(3)1626–1635
   PubMed Web of Science ®Google Scholar
• Hurt-Camejo E., Camejo G., Peilot H., Oorni K., Kovanen P. Phospholipase A2 in vascular disease. Circ. Res. 2001; 89: 298–304
   PubMed Web of Science ®Google Scholar
• Kang M. S., Jeong J. Y., Seo J. H., Jeon H. J., Jung K. M., Chin M. R., Moon C. K., Bonventre J. V., Jung S. Y., Kim D. K. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine- specific phospholipase C. Toxicol. Appl. Pharmacol. 2006; 216(2)206–215
   PubMed Web of Science ®Google Scholar
• Kim D. S., Lee E. H., Yu S. D., Cha J. H, Ahn S. C. Heavy metal as risk factor of cardiovascular disease—an analysis of blood lead and urinary mercury. J. Prev. Med. Pub. Health 2005; 38: 401–407
   PubMedGoogle Scholar
• Kostka B. Toxicity of mercury compounds as a possible risk for cardiovascular diseases. Br. J. Ind. Med. 1991; 48: 845
   PubMedGoogle Scholar
• Kuehn B. Medical Groups Sue EPA Over Mercury Rule. JAMA. 2005; 294: 415–416
   PubMed Web of Science ®Google Scholar
• Lambert I. H., Pedersen S. F., Poulsen K. A. Activation of PLA2 isoforms by cell swelling and ischemia/hypoxia. Acta Physiol. 2006; 187: 75–85
   PubMed Web of Science ®Google Scholar
• Landmark K., Aursnes I. Mercury, fish, fish oil and the risk of cardiovascular disease. Tidsskr. Nor. Laegeforen. 2004; 124: 198–200
   PubMedGoogle Scholar
• Limke T. L., Bearss J. J., Atchison W. D. Acute exposure to methylmercury causes Ca2 +dysregulation and neuronal death in rat cerebellar granule cells through an M3 muscarinic receptor-linked pathway. Toxicol. Sci. 2004; 80: 60–68
   PubMed Web of Science ®Google Scholar
• Martinez J., Moreno J. Role of Ca2+-independent phospholipase A2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 2001; 392(2)257–262
   PubMed Web of Science ®Google Scholar
• Marty M. S., Atchison W. D. Elevations of intracellular Ca2+ as a probable contributor to decreased viability in cerebellar granule cells following acute exposure to methylmercury. Toxicol. Appl. Pharmacol. 1998; 150(1)98–105
   PubMed Web of Science ®Google Scholar
• Mutter J., Naumann J., Sadaghiani C., Walach H., Drasch G. Amalgam studies disregarding basic principles of mercury toxicity. Int. J. Hyg. Environ. Health 2004; 207: 391–397
   PubMed Web of Science ®Google Scholar
• Nash R. A. Metals in medicine. Altern. Ther. Health Med. 2005; 11: 18–25
   PubMed Web of Science ®Google Scholar
• Nigam S., Schewe T. Phospholipase A2s and lipid peroxidation. Biochim. Biophys. Acta 2000; 1488: 1488, 167–181
   Web of Science ®Google Scholar
• Parinandi N. L., Scribner W. M., Vepa S., Shi S., Natarajan V. Phospholipase D activation in endothelial cells is redox sensitive. Antioxid. Redox. Signal 1999; 1(2)193–210
   PubMed Web of Science ®Google Scholar
• Phillis J. W., O'Regan M. H. The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries. Crit. Rev. Neurobiol. 2003; 15: 61–90
   PubMedGoogle Scholar
• Pleva J. Dental mercury—a public health hazard. Rev. Environ. Health 1994; 10: 1–27
   PubMedGoogle Scholar
• Reiss A. B., Edelman S. D. Recent insights into the role of prostanoids in atherosclerotic vascular disease. Curr. Vasc. Pharmacol. 2006; 4: 395–408
   PubMedGoogle Scholar
• Riendeau D., Guay J., Weech P. K., Laliberte F., Yergey J., Li C., Desmarais S., Perrier H., Liu S., Nicoll-Griffith D., Street I. P. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa Phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 1994; 269(22)15619–15624
   PubMed Web of Science ®Google Scholar
• Sarafian T. A. Methylmercury increases intracellular Ca2+ and inositol phosphate levels in cultured cerebellar granule neurons. J. Neurochem. 1993; 61(2)648–657
   PubMed Web of Science ®Google Scholar
• Sarkar B. A. Mercury in the environment: effect on health and reproduction. Rev. Environ. Health 2005; 20: 39–56
   PubMedGoogle Scholar
• Shanker G., Aschner M. Identification and characterization of uptake systems for cystine and cysteine ion cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. J. Neurosci. Res. 2001; 66: 998–1002
   PubMed Web of Science ®Google Scholar
• Shanker G., Mutkus L. A., Walker S. J., Aschner M. Methylmercury enhances arachidonic acid and cytosolic phospholipase A2 expression in primary cultures of neonatal astrocytes. Mol. Brain Res. 2002; 106: 1–11
   PubMedGoogle Scholar
• Shanker G., Syversen T., Aschner M. Astrocyte-mediated methylmercury Neurotoxicity. Biol. Trace Elem. Res. 2003; 95(1)1–10
   PubMed Web of Science ®Google Scholar
• Shanker G., Syversen T., Aschner J. L., Aschner M. Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Mol. Brain Res. 2005; 137: 11–22
   PubMedGoogle Scholar
• Valko M., Morris H., Cronin M. T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005; 12(10)1161–1208
   PubMed Web of Science ®Google Scholar
• Varadharaj S., Steinhour E., Hunter M. G., Watkins T., Baran C. P., Magalang U., Kuppusamy P., Zwier J. L., Marsh C. B., Natarajan V., Parinandi N. L. Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: regulation by MAP kinases. Cell Signal 2006; 18: 1396–1407
   PubMed Web of Science ®Google Scholar
• Verity M. A., Sarafian T., Pacifici E. H. K., Sevanian A. Phospholipase A2 stimulation by methylmercury in neuron culture. J. Neurochem. 1994; 62: 705–714
   PubMed Web of Science ®Google Scholar
• Wakita Y. Hypertension induced by methylmercury in rats. Toxicol. Appl. Pharmacol. 1987; 89: 144–147
   PubMed Web of Science ®Google Scholar
• Xu J., Yu S., Sun A. Y., Sun G. Y. Oxidant-mediated AA release from astrocytes involves cPLA2 and iPLA2. Free Radic. Biol. Med. 2003; 34(12)1531–1543
   PubMed Web of Science ®Google Scholar
• Yoshizawa K., Rimm E. B., Morris J. S., Spate V. L., Hsieh C. C., Spiegelman D., Stampfer M. J., Willett W. C. Mercury and the risk of coronary heart disease in men. N. Engl. J. Med. 2002; 347: 1755–1760
   PubMed Web of Science ®Google Scholar